Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.25 1.5% 16.875 16.25 17.50 16.875 16.625 16.63 274,064 14:00:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.4 -0.9 - 26

Skinbiotherapeutics Share Discussion Threads

Showing 7676 to 7699 of 8050 messages
Chat Pages: Latest  310  309  308  307  306  305  304  303  302  301  300  299  Older
DateSubjectAuthorDiscuss
23/9/2020
15:50
Not surprised to see the buys coming in at this unreasonably low price, despite my whinge I am invested here and see a serious re-rate come the January psoriasis trial, just disappointed in the way the lack of clarity re the options arrangement and delayed timing.
aquaesulis01
23/9/2020
15:24
Few buys coming in as we head to the close.
rafboy
23/9/2020
14:25
If you believe the CEO has never had an opportunity to buy shares, ever since he joined the company because he's permanently aware of price sensitive information then I suggest its not me whose the naïve one here! And even if it were true, then how could he be issued options exercisable at 9.5p in April, when at the time he was sat on price sensitive information? 'The grant, acceptance, acquisition, disposal, exercise of any option to acquire or dispose of securities in the company is a "deal" and therefore cannot happen in a prohibited period (i.e a period which is a close period (because results will be announced) or where there is inside information).' ...So either he was in a close period and should not have been granted options. Or, he wasn't in a close period and could have bought shares, but chose not to - even at below 9p.
someuwin
23/9/2020
13:14
He is exercising warrants attached to options granted according to your attachment. He's not adding to his holding from personal funds.
madaboutmed
23/9/2020
13:13
If its the same Paul Johnson I'm thinking off, who was previously accused of pumping and dumping, false representation via VOX Markets and Momentous Events, and has allegedly been or being investigated by the authoroties, then bargepole springs to mind.
pj 1
23/9/2020
13:06
So PJ, how on earth does Paul Johnson, CEO of PowerMetalResources find an opportunity to add to his holdings, when Stuart with far less emerging news seemingly can't? Date Source Headline 23rd Sep 2020 7:00 am RNS Director dealings 22nd Sep 2020 3:50 pm RNS Director/PDMR Shareholding 22nd Sep 2020 7:00 am RNS Canadian Silver Project - Exploration Update 22nd Sep 2020 7:00 am RNS Australia Gold JV - NI 43-101 Report Received 21st Sep 2020 7:00 am RNS New Strategic Joint Venture Established - Botswana 16th Sep 2020 3:00 pm RNS Australia Gold JV - Additional Project Reports 14th Sep 2020 1:30 pm RNS Canadian Silver Project - Option Exercised 11th Sep 2020 9:03 am RNS Holding(s) in Company 10th Sep 2020 5:18 pm RNS Exercise of Warrants 9th Sep 2020 7:00 am RNS Canadian Silver Project - Exploration Update 9th Sep 2020 7:00 am RNS Director interest in share capital 4th Sep 2020 4:52 pm RNS Exercise of Warrants 4th Sep 2020 1:21 pm RNS Business Operational Update
aquaesulis01
23/9/2020
13:02
Exactly right. All this was explained in a podcast the last time someuwin brought up the same argument. He conveniently forgets SBTX has a very small team and are all likely to be in the know when discussions are underway. It's not unreasonable to expect someuwin to know this. For someone that has been investing for as long as someuwin has he seems remarkably naive.
slartybartfaster
23/9/2020
12:26
Not sure that would lure the talent required from the private sector to AIM. As long as the options are linked to stretched performance then I have no problem. If they win then we win.
madaboutmed
23/9/2020
12:24
Spot on PJ.
madaboutmed
23/9/2020
12:22
Why does a basic salary and pension contributions not incentivise Directors? Why not incentivise with the goal of (future) dividends based on free cash flow, so not only do Directors benefit but shareholders do as well? Just like most Directors.
pj 1
23/9/2020
12:18
someuwin23 Sep '20 - 10:44 - 6660 of 6665 0 1 0 Board members are always in close(d) periods leading up to results announcement. At that point they are no longer in a closed period because they've just updated the market on all relevant facts. He could buy if he wanted. He choses not to imo. ================================================================================== Incorrect, as any share purchase by a Director other than the Chairperson has to be authorised by the Chairsperson and/or NOMAD. If price sensitive information such as contract discussions/ negotiations or product development were not in the public domain, and price sensitive, then the 'closed period' would still be relevant irrespective of other information published in any trading, half year, or full year update.
pj 1
23/9/2020
12:13
first date should read 2019 not 2018
aquaesulis01
23/9/2020
12:03
mad; it would be helpful if the Company explained the logic for setting the value of the options. I suspect the option price is set based on the share price on the award date; hence on April 18th 2018 the share price was 17.5p and hence the options awarded to Stuart were set at 18p, whilst on the date of the options awarded to Stuart in 2020 (17th April), the share price had collapsed because of the Covid situation, to 8.5p. It is unfortunate and inexplicable that the company failed to announce the award at the time, because announcing it at a time when the share price had recovered to 19p sent out a very negative message.
aquaesulis01
23/9/2020
10:25
There are usually various options. The recent grant to the CSO and CEO appear to be triggered by new commercial agreements and / or a target share price that is normally considerably higher than it stands at the time of issue so they are incentivised to deliver commercial deals / revenue to achieve the triggers and thus drive the share price upwards. IMHO DYOR
madaboutmed
23/9/2020
10:21
I do indeed hold a position here and happy to continue to build on that. I also agree that incentives that ultimately make our investments more valuable can only be a good thing.
madaboutmed
23/9/2020
09:58
Do they buy shares ? or just give them self shares ?
christopher logsdon
23/9/2020
09:56
I wouldn't assume anything my fellow investor,I presume you have a financial interest here? I certainly have. options are a one way bet.they can only win, i'm happy for them to line their pockets as long as they line mine as well
christopher logsdon
23/9/2020
09:44
Board members are always in close(d) periods leading up to results announcement. At that point they are no longer in a closed period because they've just updated the market on all relevant facts. He could buy if he wanted. He choses not to imo.
someuwin
23/9/2020
09:40
Oh that's right. You don't hold any do you. Troll
madaboutmed
23/9/2020
09:39
So sell your shares and leave us long term holders in peace.
madaboutmed
23/9/2020
09:39
You clearly have not listened to any of the interviews. He has very clearly stated that he has been in a closed position as there are only 3 members of staff and as such is unable to invest by law. He makes all of the strategic calls and as such is constantly inside. He also took a massive drop in salary to run this company. I am assuming you have never met the man? I met him at the share presentation last year and accept his explanation. He is a very straight shooter. Why not email him I am sure he will answer any question you have. He has always responded to my emails. Hope this helps you.
madaboutmed
23/9/2020
09:36
Quite right Aquae, if the CEO doesn't think it's worth buying any shares here why should anyone else?
someuwin
23/9/2020
09:32
It was at the time the options were granted. Read the RNS. I assume you would be happy if they both felt demotivated and resigned and the share price fell through the floor? SA delivered 2 agreements in less than a year. Let us hope that he refrains from reading the BS on these boards.
madaboutmed
23/9/2020
09:01
I understand the whining and like the attitude of Cathal Frial, CEO of Open Orphan who is the highest paid employee at just £140K, has put £2M of his own money into the company, and believes generous share options to directors are theft from shareholders, and that from a company now turning a profit, if Stuart Ashman believes the share price should currently be between 35p-60 odd p, as stated in a recent podcast with Elrico, why doesn't he put his money where his mouth is and buy some shares at the current market rate?
aquaesulis01
Chat Pages: Latest  310  309  308  307  306  305  304  303  302  301  300  299  Older
ADVFN Advertorial
Your Recent History
LSE
SBTX
Skinbiothe..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201202 23:12:25